<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF77BFB6-C66E-441F-AFE3-94353782E01C"><gtr:id>EF77BFB6-C66E-441F-AFE3-94353782E01C</gtr:id><gtr:name>University of Tokyo</gtr:name><gtr:address><gtr:line1>University of Tokyo</gtr:line1><gtr:line2>Bunkyo-Ku</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF77BFB6-C66E-441F-AFE3-94353782E01C"><gtr:id>EF77BFB6-C66E-441F-AFE3-94353782E01C</gtr:id><gtr:name>University of Tokyo</gtr:name><gtr:address><gtr:line1>University of Tokyo</gtr:line1><gtr:line2>Bunkyo-Ku</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/62E66BF6-B1D0-4FD2-B87E-7770B7349EA8"><gtr:id>62E66BF6-B1D0-4FD2-B87E-7770B7349EA8</gtr:id><gtr:firstName>Akane</gtr:firstName><gtr:surname>Kawamura</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FL003376%2F1"><gtr:id>14CF84BE-BDDC-4B6B-A571-ADA37A574D8A</gtr:id><gtr:title>EPSRC-Royal Society fellowship engagement (2012): Development of Chemical Tools for Probing Histone Demethylases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/L003376/1</gtr:grantReference><gtr:abstractText>Please refer to attached Royal Society application</gtr:abstractText><gtr:potentialImpactText>Please refer to attached Royal Society application</gtr:potentialImpactText><gtr:fund><gtr:end>2016-10-23</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2013-04-24</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>299740</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Emily Flashman</gtr:description><gtr:id>0CCEA259-6FD1-4D59-B07E-236F67409677</gtr:id><gtr:impact>Currently preparing a review for submission to Epigenomics.</gtr:impact><gtr:outcomeId>546470bb831346.81425649-1</gtr:outcomeId><gtr:partnerContribution>Expertise, intellectual input, training of students; use of facilities and equipment</gtr:partnerContribution><gtr:piContribution>Expertise, intellectual input, training of students; use of facilities and equipment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Target Discovery Institute</gtr:description><gtr:id>279CADB4-DD1D-4328-8E0D-13A1E1014A4A</gtr:id><gtr:impact>Multiple publications; development and distribution of chemical probes to academic and industrial researchers</gtr:impact><gtr:outcomeId>5464aaeeb27377.90718118-1</gtr:outcomeId><gtr:partnerContribution>Equipment and use of facility; generation of data</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>UAE Ganesan</gtr:description><gtr:id>284F2FCC-B84C-4979-8B3A-AFAFB5C5760F</gtr:id><gtr:impact>Manuscripts currently in preparation</gtr:impact><gtr:outcomeId>56dd8127bfbdf9.03874420-1</gtr:outcomeId><gtr:partnerContribution>Synthesis of inhibitors</gtr:partnerContribution><gtr:piContribution>Biochemical analysis of the inhibitors provided by the collaborators</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tokyo</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Hiro Suga</gtr:description><gtr:id>9F2E9DDB-81A8-44AE-9F5E-97E5BBCEB278</gtr:id><gtr:impact>Currently preparing a manuscript to submit to Nature Chemical Biology</gtr:impact><gtr:outcomeId>54642aeea1ac69.78137334-1</gtr:outcomeId><gtr:partnerContribution>My collaborators have been screening the cyclic peptide library against our targets and they have supplied the synthesised peptide hits.</gtr:partnerContribution><gtr:piContribution>In collaboration with Hiro Suga's group in University of Tokyo, we are generating a series of cyclic peptide inhibitors against various epigenetic targets. My lab has been characterising the peptides, in vitro and in cells, using biophysical and kinetic assays, crystallography and in cell activity assays.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Christopher Schofield</gtr:description><gtr:id>B6BCDFFA-F0F3-4A6E-A4B3-36D833357DD4</gtr:id><gtr:impact>Currently working closely together on a number of different projects - we have numerous published together (23 publications to date). We have a number of joint grants together, including two with BBSRC (BB/L009846/1; BB/L000121/1) and one with CRUK (C8717/A18245).</gtr:impact><gtr:outcomeId>54642d9dc59a97.90785259-1</gtr:outcomeId><gtr:partnerContribution>Expertise, intellectual input and training of staff, as well as access to facility/ equipment use.</gtr:partnerContribution><gtr:piContribution>Expertise, intellectual input and training of staff. We also provide the use of the EPSRC funded peptide synthesiser to the Schofield lab also.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk at Imperial College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>153FB109-C5E0-4678-9E1B-E3B6F1F3AE4A</gtr:id><gtr:impact>Invited talk at Imperial College, Molecular Medicine Lunchtime seminar. Following on the talk, there were good discussions and potential collaborative opportunities were identified.</gtr:impact><gtr:outcomeId>56dd8b08deac60.81475891</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Epigenetics Discovery Congress 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B210543A-A1EE-46CE-8AB7-79FD0FC72804</gtr:id><gtr:impact>Invited speaker at the Epigenetics Discovery Congress. New collaborations (academic / industry) were made as a result of my presentation.</gtr:impact><gtr:outcomeId>56dd899f9baf40.93240983</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.globaleventslist.elsevier.com/events/2015/09/the-epigenetics-discovery-congress/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discovery on Target 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E6870F9F-1C2B-4C2A-8243-ED554D720481</gtr:id><gtr:impact>I was an invited speaker at an international conference on Epigenetics Drug Discovery. The talk led to good discussions and potential collaborative opportunities.</gtr:impact><gtr:outcomeId>56dd8a11121489.30637752</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.discoveryontarget.com/Discoveryontarget_content.aspx?id=143166</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Blenheim 10K</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>45C3D513-C6EA-4EBE-9E48-E8804142241E</gtr:id><gtr:impact>BHF charity run with my research group. As researchers, we also discussed our research to the general public on the work we do.</gtr:impact><gtr:outcomeId>56dd8c622b3be3.55238308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.bhf.org.uk/get-involved/events/runs/blenheim-palace-half-marathon-10k-and-family-fun-run</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Phenotype</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>28F6BDD4-B411-4C23-A588-676F5F64E0BC</gtr:id><gtr:impact>Postdoc in my team wrote an article about the group's research, which has led to a number of researchers contacting the group for further discussions on our work</gtr:impact><gtr:outcomeId>56dd8740bfc009.69804131</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://oxphenotype.wix.com/oxphenotype15</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Periodic</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32B9BA9D-9BB0-4E24-ADF7-FFE8143947D7</gtr:id><gtr:impact>My research was highlighted in the Oxford Chemistry Alumni magazine, Periodic.</gtr:impact><gtr:outcomeId>56dd8b82b318e0.82115659</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://www.chem.ox.ac.uk/Periodic2015/files/basic-html/index.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Innovation</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C46047E-1E24-4FBE-83DC-F7F836ED82C6</gtr:id><gtr:impact>My research has attracted public interest and an article featuring my research was published in International Innovation (special Women in Science, 3rd Edition). This has prompted a number of contacts from the media requesting my input into the research field.</gtr:impact><gtr:outcomeId>56dd880f965091.31354485</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.internationalinnovation.com/build/wp-content/uploads/2015/02/p58-59_Akane_Kawamura_Intl_Innovation_171_Research_Media.pdf</gtr:url><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk at UEA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>427D6C6A-D7FB-4004-B11B-D5DCBC8946CC</gtr:id><gtr:impact>Invited speaker at School of Pharmacy at University of East Anglia, to discuss my research on Epigenetics.</gtr:impact><gtr:outcomeId>56dd8a8958c2e0.21936299</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Epigenetics in Drug Discovery, SelectBio, Cambridge, UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>091B0435-0005-4A6F-ACFD-7C1C5F8E6F06</gtr:id><gtr:impact>Conference focused on drug discovery in Epigenetics; audience included academic and industrial researchers; dissemination of data, networking and strengthened existing collaborations (and potential ones); Invited to become an editor for a volume on the chemical biology book series from the Royal Society of Chemistry</gtr:impact><gtr:outcomeId>58c7b46d0903c2.39680519</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>https://selectbiosciences.com/conferences/agenda.aspx?pid=4770&amp;conf=EDD2017</gtr:url><gtr:year>2010,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CRUK Open Doors</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8B0AFC31-D66D-440A-9B5D-5F840C7F8FCD</gtr:id><gtr:impact>Joanna Bonnici, a Research Assistant in the lab, was involved in showing people around the Chemistry Department and discussing our group's research on cancer during this CRUK run event</gtr:impact><gtr:outcomeId>56dd8ce0986124.69646446</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.oxfordopendoors.org.uk/events/chemistry-research-laboratory-5/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cancer Research UK World Cancer Day event Oxford</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>51DA70A4-CEE0-4302-98CB-172F3CC1916D</gtr:id><gtr:impact>40 general public attended this event in the Chemistry Research Laboratory, University of Oxford. This involved presentations by the CRUK organiser and Prof. Chris Schofield FRS, followed by lab tours and poster session.</gtr:impact><gtr:outcomeId>58a1bf7a516838.54258056</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CRUK Race for Life</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9A383A0A-2611-4B89-AB59-6145908F0DC4</gtr:id><gtr:impact>CRUK Race for Life charity run with my research group. As researchers, we also discussed our research to the general public on the work we do.</gtr:impact><gtr:outcomeId>56dd8c10bc8937.14918160</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://raceforlife.cancerresearchuk.org/index.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biosense</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>88115A2B-B140-49BA-9FC4-58A30083D758</gtr:id><gtr:impact>This was a exhibition held at the University Museum of Natural History, Oxford, targeting the general audience. The general theme of the exhibition was how living organisms sense changes in their environment. The section I was involved in was on Oxygen sensing.</gtr:impact><gtr:outcomeId>56dd86893f0d27.67201686</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.museums.ox.ac.uk/content/biosense</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1758846</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starter Grant</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>679479</gtr:fundingRef><gtr:id>0C91073A-116F-42D7-84FE-DDA6BD7088BF</gtr:id><gtr:outcomeId>56dd83a5771be7.60320073</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>763416</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C8717/A18245</gtr:fundingRef><gtr:id>8B296946-D5CE-4994-A21C-834555CB4E7A</gtr:id><gtr:outcomeId>54646c91d56cc0.13445924</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BHF Centre of Research Excellence</gtr:department><gtr:description>BHF CRE Pump Priming Fund</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:fundingRef>RE/08/004</gtr:fundingRef><gtr:id>BA3EDFCD-97F1-443D-AF8C-68960EF087AC</gtr:id><gtr:outcomeId>54646da9ef2562.41756445</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>John Fell Fund</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>CE6CB4AF-F030-4127-A040-1FB199211AE5</gtr:id><gtr:outcomeId>58c7b1235cdcf2.15048182</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1440</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Vacation Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>N/A</gtr:fundingRef><gtr:id>2E771A88-8285-4E5B-A081-1FBF498CAF26</gtr:id><gtr:outcomeId>54646c0fb7ae34.56990094</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>In this project, we have developed highly selective cyclic peptide inhibitors against histone demethylases, a biomedically important enzyme family involved regulation of transcription. 
We have established a state-of-the-art peptide synthesis facility within the Department of Chemistry - this includes the introduction of EPSRC funded microwave assisted peptide synthesiser. This microwave peptide synthesizer has dramatically increased our throughput and the quality of the synthesis of complex peptides (including cyclic peptides). The cyclic peptides are then tested in vitro and in cells against the enzyme targets. We have established cellular assays to assess stability, permeability and target engagement of cyclic peptides. This data was crucial in taking our work on KDM4 cyclic peptides to publication (Nature Communication 2017). In addition, this facility has enabled the synthesis of a wide variety of other peptides, including that of histone substrates for the enzymes. 
We have also established in vitro platform for cyclic peptide selection against novel targets. This will allow for identification of binding sequences against new targets.
In parallel to our inhibitor development work, we have been working on functional studies on histone demethylases. We have conducted histone substrate profiling work on this family of enzymes and have found novel substrates for certain KDMs. This work was published in Epigenetics (2015) and Nature Communications (2016). We believe that our work on biochemical functional studies of KDMs will be of interest to a wide range of scientists, including both academic and pharmaceutical scientists pursuing demethylases as therapeutic targets (particularly in oncology).</gtr:description><gtr:exploitationPathways>Our findings can have wide-ranging use - firstly and most importantly in healthcare as the research outcome will most likely be useful for development of new drugs against histone demethylases (currently being actively pursued by multiple pharmaceutical / biotechnology companies, as well as academics).</gtr:exploitationPathways><gtr:id>57CD7964-D0A4-4A0C-B97A-DBC839DA9E24</gtr:id><gtr:outcomeId>5464a8e02201f0.26148482</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Potent and selective cyclic peptide inhibitors for the KDM4A-C family</gtr:description><gtr:id>9F532864-F16C-41BC-BC85-9689AE2BE27D</gtr:id><gtr:impact>To be determined (publication just accepted and in press)</gtr:impact><gtr:outcomeId>58c7b7c5ca49f4.30685308</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Chemical tools for histone demethylase</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Target engagement assays in cells</gtr:description><gtr:id>080A8156-03D3-4232-874C-E2654C660AE7</gtr:id><gtr:impact>Publication just accepted, impact to be confirmed.</gtr:impact><gtr:outcomeId>58c7b82709b387.08541956</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cellular assays for histone demethylase</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>371EF6AB-8F9C-4477-AE7D-679325CCB028</gtr:id><gtr:title>Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bbd40ba4e8909992114840bddc89ba2"><gtr:id>8bbd40ba4e8909992114840bddc89ba2</gtr:id><gtr:otherNames>Kawamura A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a35d1023484a7.90660904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3DB8F9-FF81-47D9-884A-5EB8CC31508E</gtr:id><gtr:title>Recent Progress in Histone Demethylase Inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abdafe7ac7f8a9a303c5fc9783648bf4"><gtr:id>abdafe7ac7f8a9a303c5fc9783648bf4</gtr:id><gtr:otherNames>McAllister TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56d81e1ae27189.83415953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15D85C86-7EAB-4616-8FD5-0E1C679EE9D0</gtr:id><gtr:title>Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74f82d006a672730ea7bea7d63b04e4d"><gtr:id>74f82d006a672730ea7bea7d63b04e4d</gtr:id><gtr:otherNames>Gerken PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>5a96a02d5c5776.35079690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F687823-08B1-40DC-9005-DB893626A551</gtr:id><gtr:title>Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a27e69296ec45544247c8fe29584f542"><gtr:id>a27e69296ec45544247c8fe29584f542</gtr:id><gtr:otherNames>Walport LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58a1bb821e62f7.62415518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E703041-451A-4BA4-913B-49F0B34AD4AB</gtr:id><gtr:title>Investigating d-lysine stereochemistry for epigenetic methylation, demethylation and recognition.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a18fa903e6f621d258f9e16acd0cac8"><gtr:id>2a18fa903e6f621d258f9e16acd0cac8</gtr:id><gtr:otherNames>Belle R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5a969f28b32963.95116909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C323809-BF0F-4A31-899E-FF07A6CE624D</gtr:id><gtr:title>Targeting histone lysine demethylases - progress, challenges, and the future.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/315d6bc98f5461e589680d2b00b9069c"><gtr:id>315d6bc98f5461e589680d2b00b9069c</gtr:id><gtr:otherNames>Thinnes CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>545bdb822ca343.96653825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D05F2D61-0326-4159-A8E2-6347291E8FC3</gtr:id><gtr:title>8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aa68bffb8778b1c3e9721b2f547ae70"><gtr:id>6aa68bffb8778b1c3e9721b2f547ae70</gtr:id><gtr:otherNames>Bavetsias V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56dd7d17d39508.25014822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A15DE892-3BFB-4182-8815-57DE16837D94</gtr:id><gtr:title>Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/315d6bc98f5461e589680d2b00b9069c"><gtr:id>315d6bc98f5461e589680d2b00b9069c</gtr:id><gtr:otherNames>Thinnes CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>56dd7d876c7775.93587819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CE2F772-D30A-43F0-81EC-5F7B42CFF194</gtr:id><gtr:title>Epigenetic regulation by histone demethylases in hypoxia.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea4629d067115a5278fe0d918753769d"><gtr:id>ea4629d067115a5278fe0d918753769d</gtr:id><gtr:otherNames>Hancock RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56dd7d87c27bc7.25386256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F78A223-25DF-4C90-A873-6F1C27BF2C80</gtr:id><gtr:title>Tetracyanoresorcin[4]arene selectively recognises trimethyllysine and inhibits its enzyme-catalysed demethylation</gtr:title><gtr:parentPublicationTitle>Supramolecular Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a8bc70f131b4a8bd01de55e73b45c86"><gtr:id>0a8bc70f131b4a8bd01de55e73b45c86</gtr:id><gtr:otherNames>Peacock H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58a1bc49aca402.25047652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96061959-745A-4BE6-B2EE-FEAC8598F922</gtr:id><gtr:title>Modulating carnitine levels by targeting its biosynthesis pathway - selective inhibition of &amp;Icirc;&amp;sup3;-butyrobetaine hydroxylase.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecdd0d06b6e71c2082dd583347dda4d"><gtr:id>7ecdd0d06b6e71c2082dd583347dda4d</gtr:id><gtr:otherNames>Rydzik AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>56dd7d8856f396.54745639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A71B7E1-3081-4B42-BF5F-3EA1A09A709B</gtr:id><gtr:title>Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ccc3cf76c23081ab565c054de74615b"><gtr:id>0ccc3cf76c23081ab565c054de74615b</gtr:id><gtr:otherNames>England KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2040-2503</gtr:issn><gtr:outcomeId>56dd7d874689d7.12659876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D045108-92BB-4AC2-BDA7-F9B79EE9810B</gtr:id><gtr:title>Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df336232da544c3750224ad0b1a5c34"><gtr:id>2df336232da544c3750224ad0b1a5c34</gtr:id><gtr:otherNames>Williams ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>58a1bda068ef72.80881655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9337CEB-2D23-49C1-8CF6-C5D4BDC309CC</gtr:id><gtr:title>Selective recognition of the di/trimethylammonium motif by an artificial carboxycalixarene receptor.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa5f349e6a43b6270e696eb0e5c5dcd9"><gtr:id>fa5f349e6a43b6270e696eb0e5c5dcd9</gtr:id><gtr:otherNames>Hanauer T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>58a1ba6690d3c9.67250644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6781BE-779E-400E-9E82-E8B3CD9A7037</gtr:id><gtr:title>The Activity of JmjC Histone Lysine Demethylase KDM4A is Highly Sensitive to Oxygen Concentrations.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea4629d067115a5278fe0d918753769d"><gtr:id>ea4629d067115a5278fe0d918753769d</gtr:id><gtr:otherNames>Hancock RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>58a1bab9322bd5.93117254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A9884B5-5150-4476-9D9A-5D32A6FFF0C2</gtr:id><gtr:title>Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465e003a56fd88a695fb2b2becabd563"><gtr:id>465e003a56fd88a695fb2b2becabd563</gtr:id><gtr:otherNames>Passioura T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>5aa726ae2a1d20.43474857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E80A5067-4C20-463F-8B2C-49B58CD31876</gtr:id><gtr:title>Lysine-241 has a role in coupling 2OG turnover with substrate oxidation during KDM4-catalysed histone demethylation.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea4629d067115a5278fe0d918753769d"><gtr:id>ea4629d067115a5278fe0d918753769d</gtr:id><gtr:otherNames>Hancock RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>5a969d75e84638.12875730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B13298-925F-45D8-9352-66415C95C875</gtr:id><gtr:title>5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8fc7c1e97c29c30a042662842bb2c6c"><gtr:id>e8fc7c1e97c29c30a042662842bb2c6c</gtr:id><gtr:otherNames>Hopkinson RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>56dd7d88cb7fa2.85579214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E740B51-BA5E-45C0-91AA-2B9A1DDC1CFB</gtr:id><gtr:title>A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bc7ceeb9beebd75c38b746109e9ac69"><gtr:id>8bc7ceeb9beebd75c38b746109e9ac69</gtr:id><gtr:otherNames>Schiller R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>56dd7d889ebe53.41230684</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/L003376/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>